Limited English Proficiency can Negatively Impact Disease/Treatment in Children With Cancer Compared to Those Who are English Proficient-an Institutional Study

J Pediatr Surg. 2024 May;59(5):800-803. doi: 10.1016/j.jpedsurg.2024.01.021. Epub 2024 Jan 29.

Abstract

Background: In 2013, 25.5 million people in the United States self-identified as having limited English proficiency (LEP). LEP in adults has been associated with longer hospital stays, increased adverse events, increased emergency room visits, and decreased understanding of medications prescribed. This study aims to define the relationship between LEP and outcomes in a pediatric oncologic population.

Methods: We performed a matched case-control study utilizing data from our institutional cancer database (children </ = 18, 2012-2021). LEP families were matched by disease and stage with English proficient (EP) families. Descriptive, univariate, and bivariate analysis were performed.

Results: Twenty-four LEP children were identified and matched with 77 EP children. LEP children represented 11 languages, with the most common being Spanish (42%). Statistical regression demonstrated a clinically significant trend for LEP children to have an increased mean number of unexpected hospital admissions (p = 0.04), increased number of clinic cancellations (n = 0.003), and increased emergency department visits (p = 0.05). LEP children were more likely to have Medicaid than commercial insurance (p < 0.001). There was no difference in 2-year event free or overall survival.

Conclusion: In our study cohort, LEP families are at risk for more negative treatment experiences than EP families. Further studies are needed to delineate specific causes and interventions.

Type of study: Retrospective comparative cohort study.

Level of evidence: Level III.

Keywords: Healthcare disparities; Limited English proficiency; Pediatric oncology.

MeSH terms

  • Adult
  • Case-Control Studies
  • Child
  • Cohort Studies
  • Communication Barriers
  • Humans
  • Limited English Proficiency*
  • Neoplasms* / therapy
  • Retrospective Studies
  • United States / epidemiology